secwatch / observer
8-K filed December 27, 2021, 6:59 PM ET ticker ALHC CIK 0001832466
leadership confidence high sentiment neutral materiality 0.35

Alignment Healthcare adds two independent directors, expanding board to 11 members

Alignment Healthcare, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jody Bilney

director
ALHC · Alignment Healthcare, Inc.
Effective
2022-01-01
Filed
December 27, 2021, 6:59 PM ET
On December 23, 2021, the Board of Directors of Alignment Healthcare, Inc. (the “Company”) elected Jody Bilney and Yon Yoon Jorden as directors, effective as of January 1, 2022.
Appointed

Yon Yoon Jorden

director
ALHC · Alignment Healthcare, Inc.
Effective
2022-01-01
Filed
December 27, 2021, 6:59 PM ET
On December 23, 2021, the Board of Directors of Alignment Healthcare, Inc. (the “Company”) elected Jody Bilney and Yon Yoon Jorden as directors, effective as of January 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jody Bilney was elected as director at Alignment Healthcare, Inc..

Action
elected
Role
director
Exact text from the filing
On December 23, 2021, the Board of Directors of Alignment Healthcare, Inc. (the “Company”) elected Jody Bilney and Yon Yoon Jorden as directors, effective as of January 1, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Yon Yoon Jorden was elected as director at Alignment Healthcare, Inc..

Action
elected
Role
director
Exact text from the filing
On December 23, 2021, the Board of Directors of Alignment Healthcare, Inc. (the “Company”) elected Jody Bilney and Yon Yoon Jorden as directors, effective as of January 1, 2022.
View on SEC.gov

Alignment Healthcare, Inc. filing history →

Source: SEC EDGAR
accession 0001171843-21-008690
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.